Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIZATRIPTAN vs ROACTEMRA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIZATRIPTAN vs ROACTEMRA: Safety Overview

Metric RIZATRIPTAN ROACTEMRA
Total FAERS Reports 2,896 164
Deaths Reported 68 14
Death Rate 2.3% 8.5%
Hospitalizations 479 65
Average Patient Age 44.6 yrs 51.2 yrs
% Female Patients 77.2% N/A
FDA Approval Date Apr 14, 2023 N/A
Manufacturer Panacea Biotec Limited N/A
Route ORAL N/A
Marketing Status Discontinued N/A